Inventor · disambiguated record
Axel Bouchon
Also filed as: BOUCHON AXEL
8 granted patents·18 pending applications·358 citations·filing 2002–2025
89Inventor score
Top patents by PatentIndex Score
26 records- 0197US10709779B2Nucleic acid vaccinesMODERNATX INC·Filed 2018·Granted Jul 14, 2020·36 cites·11 claims
- 0297US10022435B2Nucleic acid vaccinesMODERNATX INC·Filed 2016·Granted Jul 17, 2018·69 cites·27 claims
- 0397US9872900B2Nucleic acid vaccinesMODERNATX INC·Filed 2016·Granted Jan 23, 2018·169 cites·26 claims
- 0495US8981061B2Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereofNOVO NORDISK AS·Filed 2012·Granted Mar 17, 2015·41 cites·2 claims
- 0592US12329812B2Nucleic acid vaccinesMODERNATX INC·Filed 2024·Granted Jun 17, 2025·0 cites·1 claims
- 0692US12274743B2Nucleic acid vaccinesMODERNATX INC·Filed 2024·Granted Apr 15, 2025·0 cites·1 claims
- 0791US8231878B2Receptor trem (triggering receptor expressed on myeloid cells) and uses thereofCOLONNA MARCO·Filed 2009·Granted Jul 31, 2012·43 cites·6 claims
- 0881US2024398927A9Nucleic acid vaccinesMODERNATX INC·Filed 2022·Application pending·0 cites
- 0977US2021220467A1Nucleic acid vaccinesMODERNATX INC·Filed 2021·Application pending·0 cites
- 1073US2019008948A1Nucleic acid vaccinesMODERNATX INC·Filed 2018·Application pending·0 cites
- 1172US2019015501A1Nucleic acid vaccinesMODERNATX INC·Filed 2018·Application pending·0 cites
- 1260US2024164410A1A stable, emulsion-forming liquid composition comprising amino acidsBRAINLUXURY INC·Filed 2022·Application pending·0 cites
- 1357US2024173295A1A stable, emulsion-forming liquid composition comprising amino acidsBRAIN LUXURY INC·Filed 2022·Application pending·0 cites
- 1456US2017320946A1Receptor trem (triggering receptor expressed on myeloid cells) and uses thereofNOVO NORDISK AS·Filed 2017·Application pending·0 cites
- 1555US2009081199A1Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereofBIOXELL SPA·Filed 2008·Application pending·0 cites
- 1655US2015050354A1Modified polynucleotides for the treatment of otic diseases and conditionsMODERNA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1752US2025281088A1Training, configuring, applying, and iteratively improving ai-language-model-based happiness and wellbeing support systemsMATTER NEUROSCIENCE INC·Filed 2025·Application pending·0 cites
- 1852US2005260670A1Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereofCOLONNA MARCO·Filed 2005·Application pending·0 cites
- 1951US2016251434A1Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereofNOVO NORDISK AS·Filed 2015·Application pending·0 cites
- 2048US2003165875A1Novel receptor TREM (triggering receptor expressed on myeloid cells) and uses thereofFiled 2002·Application pending·0 cites
- 2147US2025221646A1Systems and methods for evaluating and improving neurotransmitter levels based on mobile device application dataMATTER NEUROSCIENCE INC·Filed 2025·Application pending·0 cites
- 2246US12207927B2Systems and methods for evaluating and improving neurotransmitter levels based on mobile device application dataMATTER NEUROSCIENCE INC·Filed 2021·Granted Jan 28, 2025·0 cites·48 claims
- 2346US2010305306A1Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereofBIOXELL SPA·Filed 2010·Application pending·0 cites
- 2445US2018127786A1Compositions and methods for gene editingCASEBIA THERAPEUTICS LTD LIABILITY PARTNERSHIP·Filed 2017·Application pending·0 cites
- 2540US2018085391A1Compositions and methods for the treatment of ophthalmic diseases and conditionsMODERNATX INC·Filed 2015·Application pending·0 cites
- 2640US2017002060A1Polynucleotides for the in vivo production of antibodiesMODERNA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Axel Bouchon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →